admin

Increasing investments in mental health infrastructure, particularly in developing economies, are fueling the expansion of aripiprazole availability and accessibility. Industry Overview Aripiprazole This growth is driven by increasing need for efficient treatments for schizophrenia, bipolar disorder, and major depressive disorder, among others. Aripiprazole is an atypical antipsychotic that operates as a partial agonist of the […]

Developments in formulations and growing demand for effective antihistamines drive market expansion. Industry Overview Antazoline sulfate market is set to expand steadily between 2025 and 2035, with a forecasted CAGR of around 2.6%. Growth is mainly driven by the rising incidence of allergic diseases such as conjunctivitis and rhinitis that require effective treatment using antihistamines.

Senores Pharmaceuticals Ltd. has inaugurated its newly established Greenfield Active Pharmaceutical Ingredient (API) plant on 26 February 2025 at Mehsana, Gujarat, India, and started production activities too. This strategic expansion marks a milestone in the company’s growth, while improving its capabilities in the pharmaceutical manufacturing sector. About Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd. is an

Africa mainly needs to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) to remove the dependency on imports, improve healthcare outcomes, and drive economic growth. Advancements in technologies and international collaborations can transform API manufacturing, boost African pharmaceutical development, and make Africa self-reliant. Africa’s pharmaceutical industry is at a crucial crossroads, with major developments

Former US President Donald Trump has revived global trade tensions by declaring plans to impose significant tariffs on imported pharmaceuticals and active pharmaceutical ingredients (APIs). This move is intended to bolster domestic manufacturing, however, has raised alarms about potential disruptions in the global drug supply chain and increased medication costs for consumers.   This move